JPRN-UMIN000001737已完成1 期
Phase I/II study of docetaxel, CDDP and 5-FU therapy in patients with unresectable or recurrent esophageal cancer (JCOG 0807) - Phase I/II study of docetaxel, CDDP and 5-FU therapy in patients with unresectable or recurrent esophageal cancer (JCOG 0807)
Japan Clinical Oncology Group (JCOG)0 个研究点目标入组 64 人开始时间: 2009年2月27日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 64
研究概览
简要总结
See the datails via "URL releasing results" above. Also the details can be seen in the JCOG website: http://www.jcog.jp/en/trials/index.html
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Uncontrollable diabetes mellitus or administration of insulin. 2) Simultaneous or metachronous (within 5 years) double cancers. 3) History of hypersensitivity to DOC, CDDP, 5-FU, or polysorbate 80 4) Active bacterial or fungous infection. 5) Systemic steroids medication 6) Motor paralysis or peripheral neuropathy by any reason 7) Edema by any reason 8) Interstitial pneumonia or fibroid lung 9) Psychosis 10) Pregnant or lactating women
研究者
相似试验
已完成
3 期
Randomiazed controlled trial comparing docetaxel-cisplatin combination with docetaxel alone in elderly patients with advanced non-small-cell lung cancer(JCOG0207)non-small-cell lung cancerJPRN-C000000146Japan Clinical Oncology Group(JCOG)230
已完成
3 期
Randomiazed controlled trial comparing docetaxel-cisplatin combination with docetaxel alone in elderly patients with advanced non-small-cell lung cancer(JCOG0803/WJOG4307L)non-small-cell lung cancerJPRN-UMIN000001424Japan Clinical Oncology Group(JCOG)380
已完成
2 期
Phase II study of Docetaxel and CDDP and 5-FU for metastatic esophageal cancerEsophageal cancer with distant metastasis (Stage IVb or stage IVa with N4)JPRN-UMIN000002180OGSG45
已完成
2 期
Phase II study of Docetaxel and CDDP and 5-FU for metastatic esophageal cancerPatients to be registered Esophageal cancer with distant metastasis (Stage IVb or stage IVa with N4)JPRN-UMIN000000821OGSG45
已完成
不适用
Phase 1/2 Study of Docetaxel, CDDP and 5-FU therapy in Patients With Unresectable or Recurrent Esophageal Cancernresectable or recurrent esophageal cancerJPRN-UMIN000003633Department of Surgery, Graduate School of Medicine, Osaka University49